The paper examines the binding of the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), to human serum albumin (HSA) and DNA and states (page 1, Introduction para 1) that “no studies have examined the effects of the interaction between Dp44mT and biological molecules, such as proteins and nucleic acids”. The gene discussed is ALB; the disease is cancer.